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Aims. Previous cross-sectional studies revealed inconsistent results regarding mental health treatment preferences
among the general population. In particular, it is unclear to what extent specific age groups approve psychotherapy
or psychotropic medication for the treatment of mental disorders. We explore whether treatment recommendations
of either psychotherapy or psychiatric medication change over the lifespan which includes age-related effects due to
increasing age of a person, cohort effects that reflect specific opinions during the time a person was born and period
effects that reflect societal changes.
Methods. Using data from three identical population surveys in Germany from 1990, 2001 and 2011 (combined
n = 9046), we performed age-period-cohort analyses to determine the pure age, birth cohort and time period effects asso-
ciated with the specific treatment recommendations for a person with either depression or schizophrenia, using logistic
Partial Least-Squares regression models.
Results. For both disorders, approval of both psychotherapy andmedication for a personwithmental illness increaseswith
age. At the same time, younger cohorts showed stronger recommendations particularly for psychotherapy (OR around
1.07 per decade). The strongest effects could be observed for time period with an increase in recommendation between
1990 and 2001 with odds ratio of 2.36 in depression and 2.97 in schizophrenia, respectively. In general, the treatment option
that showed the strongest increase in recommendationwasmedication for schizophrenia and psychotherapy for depression.
Conclusion. Underutilisation of psychotherapy in old age seems not to reflect treatment preferences of older persons.
Thus, special treatment approaches need to be offered for this group that seems to be willing for psychotherapy but do
not yet use it. Cohort patterns suggest that approval of psychotherapy among older persons will likely further increase
in the coming years as these people get older. Finally, strong period effects underpin the importance of changing atti-
tudes in the society. These could reflect reporting changes about psychiatric topics in the media or a general increase in
the perception of treatment options. Nevertheless, more treatment offers especially for older people are needed.
Received 24 July 2015; Accepted 8 December 2015; First published online 12 January 2016
Key words: Age-period-cohort, psychotherapy in old age.
Introduction
Mental disorders in old age are associated with higher
general health service use (Luppa et al. 2012). Yet, the
use of mental health services is often poorly matched
to needs and only one-third of all older adults with
mental disorders report ever seeking help for their
complaints such as psychiatric medication or psycho-
therapy (Wittchen & Pittrow, 2002; Cepoiu et al.
2008; Busch et al. 2013). Reasons for this misallocation
of health care resources are unclear: under-diagnosis of
mental health problems in old age is one likely barrier
to adequate treatment (Mitchell et al. 2010), but nega-
tive attitudes towards psychiatric medication or psy-
chotherapy could also play a role. Looking
specifically at attitudes towards psychotherapy and
pharmacotherapy, a study among depressed primary
care patients in the USA indicated a preference for
counselling or psychotherapy over antidepressant
* Address for correspondence: S. Van der Auwera, Department of
Psychiatry, University Medicine Greifswald, Ellernholzstraße 1-2,
17489 Greifswald, Germany. Tel: +49 (0)3834/86-22165
(Email: auweras@uni-greifswald.de)




Downloaded from https://www.cambridge.org/core. Universitaetsbibliothek Regensburg, on 21 Nov 2019 at 09:20:23, subject to the Cambridge Core terms of use, available at
medication (Gum et al. 2006), which corresponds to
population studies that consistently show stronger pre-
ferences for psychotherapy over pharmacotherapy
(Schomerus et al. 2012). However, only very few
older persons with depression receive psychotherapy,
most patients of older age receiving treatment are tak-
ing antidepressant medication (Morichi et al. 2015). On
the one hand, this is simply because guidelines for
geriatric depression recommend antidepressant medi-
cation as an initial treatment (Alexopoulos, 2011),
probably still reflecting the false belief that older per-
sons do not benefit from psychotherapy. On the
other hand, access to psychotherapy is limited
(Unützer et al. 2003) and depression in older age is
often accompanied by cognitive deficits, which might
result in under-diagnosis of mood disorders
(Morimoto & Alexopoulos, 2013; Koethe et al. 2014).
When looking at age-related differences in attitudes,
three effects need to be distinguished. Age-effects refer
to regular changes in attitudes over the lifespan, regard-
less of the year a person is born. Besides these changes
over the lifespan, cohort effects might also cause vari-
ation in attitudes between older and younger persons.
Cohort effects refer to attitudes that develop similarly
in a certain birth cohort, for example, due to a shared
cultural environment in childhood. The third time
related effect on attitudes, changes that affect the gen-
eral population regardless of age or birth cohort, is
referred to as period effects. They reflect general attitude
changes within a specific time frame, caused for
example by economic or societal changes, but potential-
ly also by population wide antistigma campaigns. Put
briefly, age effects characterise the effect of ageing,
while cohort effects characterise the effects of upbring-
ing and period effects characterise societal changes.
So far, few studies examined attitudes of older
persons towards mental health care and the existing
cross-sectional studies based on population-based
and clinical samples revealed inconsistent results
(Leaf et al. 1987; Kessing et al. 2005). A study in
Denmark found more negative attitudes towards anti-
depressant medication among older compared with
younger adults being treated for affective disorders
(Kessing et al. 2005). A population-based study in the
USA of attitudes towards mental health services in
1980 found that both younger and older participants
are more sceptical towards mental health care seeking
compared with those aged 25–64 years (Leaf et al.
1987). In contrast, analyses of the population-based
National Comorbidity Survey 1990–1992 in the USA
found a positive correlation between age and willing-
ness to seek mental health treatment (Mojtabai,
2007). So far, it is thus unclear whether attitudes
towards using mental health care differ between
younger and older persons.
Regarding period effects, attitudes of the general
population towards psychiatric treatment have chan-
ged over the last decades. Ameta-analysis of time-trend
studies from several Western industrialised countries
showed that in more recent surveys, more people
recommended drug treatment of mental disorders
than did so in earlier surveys (Schomerus et al. 2012).
Accordingly, prescription rates particularly for anti-
depressant medication are rising. Between 1999 and
2010, antidepressant use in the USA increased from 6
to 10% of the population (Olfson & Marcus, 2009;
Mojtabai &Olfson, 2014). Similarly, in OECD countries,
consumption of antidepressants rose from3 to 6 defined
daily doses (DDD) per 100 inhabitants between 2000
and 2011 (OECD. Health at a Glance 2013: http://www.
oecd.org/health/healthtaglance (accessed 26.5.2014)). A
time trend study over 21 years from Germany showed
that between 1990 and 2011, the approval rates of psy-
chotherapy for depression rose from 57 to 71%, and
for schizophrenia from 62 to 82% (Angermeyer et al.
2013a, b). A Swedish study recently reported an overall
increase in more positive attitudes toward psychother-
apy and medication between 1976 and 2014
(Mirnezami et al. 2015). While suggesting a strong
period-effect, these studies did not investigate simul-
taneously the effect of age, cohort and time period on
treatment approval. Hence, it is unclear to what extent
age of the respondents, changes in birth cohorts, or gen-
eral societal changes are responsible for the develop-
ment of preferences for psychotropic medications or
psychotherapy over time.
Aims of the study
In this paper, we examine age related differences in
attitudes towards mental health treatment by disentan-
gling age, cohort and period effects. In particular, we
use age, period and cohort analyses based on three
pooled cross-sectional studies of the German popula-
tion to examine the approval of either psychiatric




Our study is based on data from three methodologically
identical population-based cross-sectional surveys
among German citizens aged 18 years and older con-
ducted in 1990, 2001 and 2011 (Angermeyer &
Matschinger, 1997; Angermeyer et al. 2003, 2013a, b;
Schomerus et al. 2015). Aimof these surveyswas to assess
various mental health-related attitudes of the general
population cross-sectionally, and to enable time-trend
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analyses of attitudes. In all surveys, the samples were
drawn using an identical random sampling procedure
with the three stages sample points, households and indi-
viduals within the target households. Target households
within the sample points were determined according to
the random route procedure (Gabler & Hoffmeyer-
Zlotnik, 1997). Target individuals within households
were selected using random digits. Informed consent
was considered to have been given when individuals
agreed to complete the interview. Fieldwork was carried
out by GETAS (Hamburg) in 1990, and by USUMA
(Berlin) in 2001 and 2011. Data in 1990 were gathered in
two waves, wave 1 in the old German states (April
1990) and wave 2 in the new German states (November
1990) shortly after re-unification.
Interview
All interviews were conducted face-to-face using
pencil and paper. In all surveys, the fully structured
interview was identical regarding wording and the
sequence of questions. At the beginning of the inter-
view respondents were presented with a vignette of
a diagnostically unlabelled case history depicting a
person with mental illness. While several mental disor-
ders had been studied in single surveys, vignettes on
schizophrenia and major depression had been used
in three consecutive surveys and could thus be subject
of our age-period-cohort (APC) analysis. The symp-
toms described in both vignettes fulfilled the criteria
of DSM-IV for schizophrenia or depression and had
been validated by five experts in psychopathology
blinded to the diagnosis (vignettes see supplement).
While in 1990 and 2011 the sex of the individual pre-
sented in the vignettes varied at random, in 2001
only responses to a male vignette were elicited. For
the present study, we thus only use responses elicited
with the male vignette. We asked respondents treatment
recommendation for thepersondescribed in the vignette.
Presenting them with a catalogue of treatment options,
we asked: ‘Although you might not be expert, you may
have an ideawhat shouldbest be recommended to some-
one with a problem described in the vignette. Please tell
me for each option towhat extent youwould recommend
it orwouldnot recommend it.’Eliciting treatment recom-
mendations for a thirdperson is an establishedmethod to
assess mental health literacy (Reavley & Jorm, 2012).
Recently it has been shown that treatment recommenda-
tions and personal treatment preferences are closely
related (Rüsch et al. 2014). Answers were recorded
using a five-point Likert scale with the anchors 1 = ‘I
would strongly recommend it’ and 5 = ‘I would strongly
advise against it’, plus a ‘don’t know’ category. For our
present analysis, we use answers to the items ‘using psy-
chotherapy’ and ‘taking psychotropic drugs’.
Sample description
Our combined study sample from all surveys consisted
of 9046 participants, 4505 subjects receiving the depres-
sion vignette and 4541 participants receiving the schizo-
phrenia vignette. Since in both samples from 1990 the
population from the old (West-)German states was
underrepresented, we weighted this sample to achieve
a proportion of 80:20 for old and new German states
for the schizophrenia and depression sample, respect-
ively. This is representative of the overall German
population and identical to the old/new-proportions
in the samples from 2001 and 2011. Participants with
missing values in one of the analysed variables were
excluded. To aid interpretation of results, we also
excluded participants answering with ‘don’t know’
(vignette: depression + recommendation: psychother-
apy N = 356; vignette: depression + recommendation:
psychotropic medication N = 443; vignette: schizophre-
nia + recommendation: psychotherapy N = 299; vignette:
schizophrenia + recommendation: psychotropic medica-
tion N = 457). Our final study sample thus included
N = 4120 (psychotherapy) and N = 4034 (psychotropic
medication) for the depression vignette and N = 4212
(psychotherapy) and N = 4061 (psychotropic medica-
tion) for the schizophrenia vignette.
Statistical analysis
Disentangling age, cohort and period effects is meth-
odologically challenging because of the perfect collin-
earity of the three time variables (period = cohort +
age). To extract the ‘pure age related effect’ that is
not confounded by cohort or period effects, more
advanced statistical methods than simple ordinary
least-squares regression are required. For each of the
two disorders, we performed an APC analysis to test
and separate associations of age at examination, birth
cohort and time period with our two items of treat-
ment recommendation (psychotherapy and psycho-
tropic medication). This collinearity problem is
referred to as the identification problem because only
two of the three variables can be put into a regression
model simultaneously. Instead, we used partial
least-squares regressions (PLS), which allow using per-
fectly collinear variables in one regression model. In
PLS components are extracted that are weighted com-
binations of the original variables. These components
are chosen according to their relationship to the out-
come variable. They seek to maximise the covariance
between the outcome and those weighted components.
As a result, the first component has a greater covari-
ance with the outcome than the second and so on. In
a three-dimensional space with three covariates as
input variables a maximum of three PLS components
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can be extracted which are orthogonal to each other.
The regression coefficients for the three variables can
directly be obtained from their weights in each compo-
nent (Tu et al. 2012; Jiang et al. 2013). For the mathem-
atical equations see supplemental material. Bastien
et al. (2005) extended the linear PLS to generalised lin-
ear models (GLM), including binary and ordinal
regression. We used the R-package plsRglm that is
available on the CRAN archive and maintained by
Frédéric Bertrand. First, we used a GLM PLS with
logit link and binomial distribution to model binary
treatment recommendation for psychotherapy and
psychotropic medication, respectively. We dichoto-
mised the five-point Likert scales (1: ‘I would strongly
recommend’ & ‘I would recommend’ 0: ‘I would nei-
ther recommend or advise against it’ & ‘I would advise
against it’ & ‘I would strongly advise against it’). We
included age at interview and birth cohort as continu-
ous variables and two dummy variables for time per-
iod (i.e. 2011 and 2001 v. 1990) as covariates. We
performed 1000 bootstrap replications to obtain 95%
confidence intervals (CIs). To additionally examine
non-linear relationships for age and birth cohort, we
used restricted cubic splines (Harrell, 2001) in PLS
regression with five knots for age at examination and
birth cohort. Wald tests of coefficients of the second,
third and fourth spline transformation equal to zero
were used to obtain p values for nonlinearity. Wald
tests indicated that age and cohort were linearly related
to all outcomes. To assess themodel fit of linear and non-
linear PLS,we compared the pseudoR2, which is ameas-
ure of the variance of the outcome variable that can be
explained by the covariates, analogous to ordinary
least-squares regression. Because PLS penalises variables
according to their variance when extracting the compo-
nents, covariates were scaled to have unit variance and
zero mean. To validate our results, we conducted two
additional sensitivity analyses detailed in the supple-
ment. First, we included those participants that had
answered with the ‘don’t know’ category by coding
them as denial of treatment (i.e. ‘I would strongly advise
against it’) in the binary logistic regression. Second, we
performed an ordered logistic regression included in
the plsRglm package with the five response categories
of the Likert scale (setting respondents with ‘don’t
know’ tomissing). To test the proportional odds assump-
tion underlying the ordered logit model, we used a
graphical method proposed by Harrell (2001) because
other statistical tests have the tendency to reject the null
hypothesis. Analyses were performed using the statistic-
al software R (version 3.0.2).
Results
In the pooled cross-sectional data age at examination
ranged from 18 to 93 and birth cohort from 1900
to 1993. Table 1 shows the number of individuals in
each age group and stratified by type of vignette for
1990, 2001 and 2011 (see Supplementary Table S1 for the
number of individuals per birth cohort). For more
details on the distribution of age and birth cohort with
respect to their recommendation see Supplementary
Fig. S1. The mean age was 47 for both samples and
Table 1. Number of subjects of each age group at each time period
1990 2001 2011 1990 2001 2011
Age Psychotherapy Psychotropic medication
Depression vignette (N = 4120) (N = 4034)
<30 270 417 76 263 413 72
30–39 231 508 87 223 487 87
40–49 196 430 113 194 417 105
50–59 192 335 106 199 336 98
60–69 176 411 88 170 419 78
≥70 103 279 102 105 278 90
Recommending therapy 635 (65%) 1,793 (75%) 433 (76%) 263 (23%) 995 (42%) 205 (39%)
Schizophrenia vignette (N = 4212) (N = 4061)
<30 307 382 69 291 370 66
30–39 262 498 92 250 491 80
40–49 205 467 107 204 451 102
50–59 211 332 99 202 326 98
60–69 195 387 114 184 375 101
≥70 115 271 99 108 270 92
Recommending therapy 883 (68%) 2034 (87%) 506 (87%) 346 (28%) 1371 (60%) 329 (61%)
64 S. Van der Auwera et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S2045796015001134
Downloaded from https://www.cambridge.org/core. Universitaetsbibliothek Regensburg, on 21 Nov 2019 at 09:20:23, subject to the Cambridge Core terms of use, available at
mean birth cohort was 1952. The depression and schizo-
phrenia samples had 44 and 46% males, respectively.
Model fit
In all PLS analyses, a two-component model showed
better model-fit than a one-component model and a
similar model fit to the three-component model
(see Supplementary Table S2). We thus report results
for the two-components logistic PLS models only
(Table 2). In depression, the two components PLS
model explained 4.07% of the variance (pseudo R2) for
recommending psychotherapy and 3.63% for psycho-
tropic medication (one-component model: psychother-
apy 3.74%; psychotropic medication 2.98%). In total,
69.4%of all participantswould recommendpsychother-
apy and 36.3% psychotropic medication in case of
depression irrespective of age, birth cohort or period.
For schizophrenia, themodelwith twoPLS components
explained 4.85%of the variance for the treatment recom-
mendation psychotherapy and 9.23% for psychotropic
medication (one-component model: psychotherapy
4.36%; psychotropic medication 8.24%). Overall 81.3%
recommend psychotherapy and 50.4% psychotropic
medication as treatment for schizophrenia.
Age effects
For the depression vignette, age was significantly asso-
ciated with an increase of both treatment recommen-
dations with similar effect sizes (psychotherapy OR
per decade = 1.09; psychotropic medication OR per
decades = 1.10) independent from cohort and period
effects (Table 2). Over the lifespan of 60 years the
odds for recommending psychotherapy increases to
OR = 1.69 and to OR = 1.82 for psychotropic medication
(Fig. 1). In schizophrenia, both recommendations also
showed a significant age effect (Table 2). Likewise,
we observed an OR of 1.06 per decade for the recom-
mendation of psychotherapy and even higher, OR =
1.16 per decade, for recommending psychotropic
medication. Over the lifespan (60 years) this cumulates
to an increase of ORs to 1.44 and 2.55 for recommend-
ing psychotherapy and psychotropic medication,
respectively (Fig. 1).
Cohort effects
In depression, an effect of birth cohort on treatment rec-
ommendation could only be observed for psychother-
apy (OR = 1.07 per decade) with greater approval in
persons born in more recent birth cohorts. Over a
time period from cohorts 1930 to 1990 this increases
OR to 1.53.
For schizophrenia, both treatment recommendations
also showed a significant cohort effect with similar
effect sizes (ORs per decade of 1.08 and 1.06 for psycho-
therapy and medication, respectively). Participants
born in later years indicated stronger recommendation
for both treatment options, irrespective of age and per-
iod effects. Comparing early and most recent birth
cohorts over 60 years (1930–1990), this effect cumulated
Table 2. Treatment recommendations towards a person with schizophrenia or depression: age, period and cohort effects.
Psychotherapy Psychotropic medication
OR 95% CIa OR 95% CIa
Schizophrenia
Age (years) 1.006 (1.002, 1.010) 1.016 (1.014, 1.018)
Cohort (years) 1.008 (1.007, 1.010) 1.006 (1.004, 1.009)
Period (1990 ref.)
2001 2.967 (2.523, 3.466) 3.589 (3.176, 4.133)
2011 2.361 (1.708, 3.277) 3.344 (2.543, 4.076)
R2 4.85% 9.23%
Depression
Age (years) 1.009 (1.006, 1.012) 1.010 (1.008, 1.013)
Cohort (years) 1.007 (1.004, 1.009) 1.001 (0.999, 1.004)
Period (1990 ref.)
2001 2.361 (2.068, 2.747) 2.430 (2.109, 2.881)
2011 2.254 (1.773, 2.804) 1.517 (1.244, 2.032)
R2 4.07% 3.63%
Logistic PLS regression with two components. Unstandardised coefficients.
aCI after 1000 non-parametric Bootstrap replicates.
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to an OR = 1.62 and OR = 1.46 for psychotherapy and
psychotropic medication, respectively (Fig. 1).
Taken together, age and cohort effects indicate
higher attitudes both over the lifespan and in coming
years, when more recent cohorts grow older.
Period effects
For time period, we calculated the effects for the
three distinct time points. In depression, time period
had a strong effect on treatment recommendations.
Participants from more recent surveys indicated higher
approval for the treatment options than the reference
sample from 1990. The OR for choosing psychotherapy
was 2.361 in 2001 and 2.25 in 2011, when 1990 served
as reference category. For psychotropic medication,
ORs were 2.43 in 2001 and 1.52 in 2011 (with 1990 as
reference category). Using 2001 as reference category
yielded no significant change between 2001 and
2011, neither for psychotherapy nor for psychotropic
medication.
Similar to depression a significant period effect
could be observed in schizophrenia for both treatment
recommendations, particularly for psychotropic medi-
cation. People from the more recent surveys were more
likely to recommend both treatment options. The OR
for recommending psychotherapy were 2.97 in 2001
and 2.36 in 2011, compared with 1990. The decline
between 2001 and 2011 was not significant when
2001 served as the reference group. For psychotropic
Fig. 1. Cumulative effect of age, cohort and period on treatment recommendations for schizophrenia and depression.
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medication the OR in 2001 was 3.59 and 3.34 in 2011,
which is a relatively stable approval for this treatment
between 2001 and 2011. Again, the decrease in treat-
ment recommendation between 2001 and 2011 was
not statistically significant.
Using the full sample by including the ‘don’t know
category’ as potential denial of treatment did not change
the overall associations (Supplementary Table S3).
Similarly, ordinal logistic regression on the five-point
Likert scale showed overall similar results to those pre-
sented in the main analysis (Supplementary Table S4)
indicating a robust model.
In summary, we found improving attitudes over
time. Recommendation increases with growing age,
in more recent birth cohorts, and generally improved
over the last 20 years (Fig. 1). Differences in the APC
pattern for treatment recommendations between
schizophrenia and depression were primarily observed
for recommending psychotropic medication.
Discussion
The first positive conclusion we can draw from our
analyses is that no treatment recommendation showed
a significant decrease irrespective of vignette, growing
age, birth cohort or time period. The by far strongest
effects were observed for time period, especially
between 1990 and 2001. Obviously there has been a gen-
eral rise in acceptance for professional mental health
treatment, a trend that has been described and
discussed previously (Angermeyer & Matschinger,
2005; Mojtabai, 2007). In our study, this trend peaked
in 2001, with no significant further increase in
treatment recommendations between 2001 and 2011.
Disentangling this trend from any age and cohort
effects, our study corroborates the notion that psychi-
atric treatment has generally gained acceptance over
the last 20 years (Angermeyer et al. 2013b). These
changes have been attributed to changes within psychi-
atric services following psychiatric reform, to increasing
mental health literacyof the general population, but also
to a more biological understanding of mental disorders
(Angermeyer & Matschinger, 2005; Mojtabai, 2007;
Angermeyer et al. 2013b). Since our study is the first to
look at age and cohort effects in treatment recommenda-
tions for mental disorders, we will focus our discussion
on this novel part of our results. Our findings show that
there is no reason to suspect that particularly psycho-
therapy receives less support among older compared
with younger persons. Especially for depression, psy-
chotherapy as well as psychotropic medication show a
similar increase in popularity with growing age. In
our sample, 71.5% of the participants aged 70 years
and above recom mended psychotherapy and 47.1%
recommendedmedication. In schizophrenia, the recom-
mendation for psychotropicmedication showed amuch
stronger increase than psychotherapy but both treat-
ment options are highly recommended in old age (psy-
chotherapy 78.6% and psychotropic medication 60.2%
in people of age ≥70 in our sample). The higher recom-
mendation rates in schizophrenia could reflect the
greater perceived severity of schizophrenia as depicted
in our vignettes, highlighting a stronger necessity for
treatment. Accordingly, the percentage of the subjects
in the survey 2011 considering the person described as
suffering from a ‘mental illness in a medical sense’
was 83% in schizophrenia compared with 65% in
depression (Schomerus et al. 2013). If schizophrenia is
more frequently seen as a medical problem, a higher
rate of professional treatment recommendations seems
plausible.
Depression among older persons is very common,
affecting between 10 and 15% of older persons living
in the community (Beekman et al. 1999). Facing the
challenge of an ageing society and a rising number
of geriatric patients in the future, adequate treatment
options are required. Although antidepressant use
especially in the elderly has increased (Olfson &
Marcus, 2009), only one-third of older patients achieve
remission (McGovern et al. 2014). Pharmacotherapy
with antidepressants in older persons is also associated
with higher all-cause mortality (Coupland et al. 2011).
Older persons are more likely to exhibit adverse drug
effects due to multi-morbidity and the high number of
prescribed medications (Dines et al. 2014). Moreover,
meta-analyses show similar effect sizes for pharmaco-
therapy and psychotherapy in older persons with
depression (Pinquart et al. 2007). Provision of psycho-
therapy should thus complement pharmacotherapy
or could even be a safer alternative to medication. It
is becoming increasingly recognised that older people
represent a suitable target group for psychotherapy
due to their better emotional regulation skills, increased
wisdom and resilience mechanisms accumulated over
many years of experience (Laidlaw, 2013). Our findings
support the willingness of this patient group to under-
take psychotherapy in case of depression.
The particular merits of disentangling age, cohort
and period effects are illustrated by the fact that both
older age and a more recent birth cohort are associated
with stronger approval of mental health treatment.
This finding might level differences between older
and younger respondents in cross-sectional assess-
ments, but our analyses indicate that prospectively,
the popularity of professional treatment among older
persons will further increase when younger cohorts
grow older. In depression, this is particularly true for
psychotherapy, where younger cohorts that are even
more open minded towards psychotherapy will
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become the new generation of older people. The strong
period effects found in this study, yielding continuous-
ly higher recommendation rates for psychotherapy
in more recent surveys compared with 1990, also
supports this trend. Conversely, attitudes towards
pharmacotherapy of depression seem to have peaked:
they do not improve in younger cohorts, and between
2001 and 2011 there seems to be an overall (although
insignificant) decline in approval. Generally, the strong
period effects found in this study show that attitudes
towards mental health treatment are changeable,
which is an encouraging finding for future awareness
and prevention programs.
Treatment recommendations for a person with
schizophrenia also increased with age. Regarding spe-
cific treatment options for older people, this seems less
important. First, approval rates for both medication
and psychotherapy are generally high in schizophre-
nia, so age-related effects are less relevant. Second,
schizophrenia mainly starts at younger age and is
thus of less personal relevance for older persons.
Nevertheless, our concordant findings on schizophre-
nia and depression suggest that greater openness par-
ticularly towards psychotherapy is not restricted to a
specific diagnosis, but is reflecting a general change
of mental health related attitudes. This is especially
visible in the strong period effect of increased overall
approval of treatment options between 1990 and 2001.
Our study has several limitations that need to be
considered. First, we elicited treatment recommenda-
tions for another person, and not personal treatment
preferences. However, there is evidence that recom-
mendations for others and personal preferences are
closely related (Rüsch et al. 2014). Examining recom-
mendations is also relevant in itself, because advice
from a friend or family member is one of the main
sources of information in case of help seeking for psy-
chiatric disorders (Rüsch et al. 2014). But it must also
be noted that at the end the recommendation of the
doctor has a great influence on treatment decision,
too. Thus, it may be interesting to analyse the changes
in treatment preferences of primary care physicians.
Other factors besides the three-time variables exam-
ined in this study might determine recommendations
regarding mental treatment options. These may be
sex, education or prior contact to people with mental
disorders. This study aimed to examine and compare
age relative to cohort and period effects. Future studies
will help to examine whether this effects are attribut-
able to other potential confounding, effect-modifying
factors and mediators.
In summary, our study shows that both medication
and psychotherapy are becoming more popular over
the lifespan. Increasing the provision of psychotherapy
for older persons in need would be perfectly in line
with treatment preferences elicited among the general
population.
Supplementary materials
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